stars 1 stars 2 stars 3

SpecificiT Pharma Inc., a privately held biopharmaceutical company focused on developing innovative personalized cancer immunotherapies. SpecificiT is developing cellular therapies for hematological cancers which to date, cannot be treated with chimeric antigen receptor modified T cells (CAR-T) therapies. SpecificiT’s unique approach is centered on the use of Minor Histocompatability Antigens (“MiHAs”) which enable donor T-cells to be safely directed to eliminate cancer cells in a patient.

SpecificiT Pharma Inc. Questions

The SpecificiT Pharma Inc. annual revenue was $608000 in 2026.

SpecificiT Pharma Inc. is based in Montreal, Quebec.

The NAICS codes for SpecificiT Pharma Inc. are [54171, 54, 541, 5417, 541711].

The SIC codes for SpecificiT Pharma Inc. are [283, 28, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users